{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:50:17Z","timestamp":1791391817680,"version":"4.3.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Inflammatory bowel diseases (IBD) have been associated with adverse outcomes during pregnancy, with guidelines developed to inform clinical practice. This study reviewed adherence to guidelines amongst different healthcare providers caring for individuals with IBD during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective multi-centre study of individuals with IBD who received antenatal IBD care at three Australian tertiary units from 2023 to 2025 was undertaken. Clinical documentation for each pregnancy was reviewed against nine\u00a0process indicators derived from the European Crohn\u2019s and Colitis Guidelines on Sexuality, Fertility, Pregnancy and Lactation [1]. The primary outcome was the proportion of process indicators followed by speciality per pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-three pregnancies amongst 43 individuals were included; 19 (44.2%) had ulcerative colitis. Twenty-six pregnancies (60.5%) were to individuals on biologic therapy for IBD at time of conception. Gastroenterologists met a median 6\/9 (67%) process indicators, Obstetrics\/Maternofetal Medicine specialists met a median 3\/9 (33%) process indicators, and Other Specialists (combined) met a median 1\/9 (11%) process indicators per pregnancy. The number of clinic visits and proportion of process indicators followed correlated positively. Adherence to preconception counselling, mental health assessment, and venous thromboembolism risk assessment was particularly poor, completed by Gastroenterology in 39.5, 34.9 and 4.7% of cases, respectively, compared to 4.7, 25.6 and 46.5% of cases by obstetric care providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Uptake of guideline recommendations for antenatal IBD management was variable between different speciality providers in this study of patients with moderate-to-severe IBD. Uptake of recommendations may be improved by increasing access to multidisciplinary care and frequent clinical contact. Whether improvements in adherence with process indicators translates to improved clinical outcomes warrants further evaluation in IBD pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10620-026-10246-8","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:55:09Z","timestamp":1791388509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reflecting on Quality-of-Care Delivery in Inflammatory Bowel Disease Pregnancy: The (Pause and Reflect) PAUSA Study"],"prefix":"10.1007","author":[{"given":"Simone","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Demase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crispin","family":"Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Paizis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralley","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"De Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"10246_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","volume":"17","author":"J Torres","year":"2021","unstructured":"Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, Ardizzone S, Campmans-Kuijpers M, Dragoni G, Ferrante M, Fiorino G, Flanagan E, Gomes CF, Hart A, Hedin CR, Juillerat P, Mulders A, Myrelid P, O\u2019Toole A, Riviere P, Scharl M, Selinger CP, Sonnenberg E, Toruner M, Wieringa J, Van der Woude CJ. European Crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J Crohn\u2019s Colitis 2021;17:1\u201327. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac115.","journal-title":"J Crohn\u2019s Colitis"},{"key":"10246_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/ibd.21209","volume":"16","author":"J Wilson","year":"2010","unstructured":"Wilson J, Hair C, Knight R, Catto-Smith A, Bell S, Kamm M, Desmond P, McNeil J, Connell W. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis 2010;16:1550\u20131556. https:\/\/doi.org\/10.1002\/ibd.21209.","journal-title":"Inflamm Bowel Dis"},{"key":"10246_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252458","volume":"16","author":"D Busingye","year":"2021","unstructured":"Busingye D, Pollack A, Chidwick K. Prevalence of inflammatory bowel disease in the Australian general practice population: a cross-sectional study. PLoS One 2021;16:e0252458. https:\/\/doi.org\/10.1371\/journal.pone.0252458.","journal-title":"PLoS One"},{"key":"10246_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/apt.15587","volume":"51","author":"P Tandon","year":"2020","unstructured":"Tandon P, Govardhanam V, Leung K, Maxwell C, Huang V. Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease. Aliment Pharmacol Therapeut 2020;51:320\u2013333. https:\/\/doi.org\/10.1111\/apt.15587.","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10246_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129567","volume":"10","author":"HA Boyd","year":"2015","unstructured":"Boyd HA, Basit S, Harpsoe MC, Wohlfahrt J, Jess T. Inflammatory bowel disease and risk of adverse pregnancy outcomes. PLoS One 2015;10:e0129567. https:\/\/doi.org\/10.1371\/journal.pone.0129567.","journal-title":"PLoS One"},{"key":"10246_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5694\/mja2.50062","volume":"210","author":"SJ Bell","year":"2019","unstructured":"Bell SJ, Flanagan EK. Updates in the management of inflammatory bowel disease during pregnancy. Med J Aust 2019;210:276\u2013280. https:\/\/doi.org\/10.5694\/mja2.50062.","journal-title":"Med J Aust"},{"key":"10246_CR7","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/1471-0528.13946","volume":"123","author":"AW Shand","year":"2016","unstructured":"Shand AW, Chen JS, Selby W, Solomon M, Roberts CL. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes. BJOG 2016;123:1862\u20131870. https:\/\/doi.org\/10.1111\/1471-0528.13946.","journal-title":"BJOG"},{"key":"10246_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/gutjnl-2022-329304","volume":"72","author":"R Laube","year":"2023","unstructured":"Laube R, Selinger CP, Seow CH, Christensen B, Flanagan E, Kennedy D, Mountifield R, Seeho S, Shand A, Williams A, Leong RW. Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut 2023;72:1040\u20131053. https:\/\/doi.org\/10.1136\/gutjnl-2022-329304.","journal-title":"Gut"},{"key":"10246_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/flgastro-2020-101459","volume":"12","author":"C Selinger","year":"2020","unstructured":"Selinger C, CareyN Cassere S, Nelson-Piercy C, Fraser A, Hall V, Harding K, Limdi J, Smith L, Smith M, Gunn MC, Mohan A, Mulgabal K, Kent A, Kok KB, Glanville T. Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British society of gastroenterology and the British maternal and fetal medicine society. Front Gastroenterol 2020;12:182\u2013187. https:\/\/doi.org\/10.1136\/flgastro-2020-101459.","journal-title":"Front Gastroenterol"},{"key":"10246_CR10","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","volume":"156","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American gastorenterological association IBD parenthood project working group. Gastroenterology 2019;156:1508\u20131524. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.022.","journal-title":"Gastroenterology"},{"issue":"10","key":"10246_CR11","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/ibd\/izaf171","volume":"31","author":"Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD","year":"2025","unstructured":"Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G,Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD.  Global consensus statement on the management of pregnancy in inflammatory bowel disease. Inflamm Bowel Dis 2025;31(10):2615\u20132664. https:\/\/doi.org\/10.1093\/ibd\/izaf171","journal-title":"Inflammatory BowelDiseases."},{"key":"10246_CR12","doi-asserted-by":"publisher","unstructured":"de Lima A, Zelinkova Z, Mulders AGMGJ, van der Woude C. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol 2016;14:1285\u20131291.e1. https:\/\/doi.org\/10.1016\/j.cgh.2016.03.018","DOI":"10.1016\/j.cgh.2016.03.018"},{"issue":"7","key":"10246_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ibd\/izad147","volume":"30","author":"S Lee","year":"2024","unstructured":"Lee S, Seow CH, Nerenberg K, Bertazzon S, Leung Y, Huang V, Whitten T, Coward S, Panaccione R, Kaplan GG, Metcalfe A. Despite increased disease activity, women who attended a dedicated inflammatory bowel disease and pregnancy clinic had infants with higher Apgar scores: a population-based study. Inflamm Bowel Dis 2024;30(7):1071\u20131079. https:\/\/doi.org\/10.1093\/ibd\/izad147","journal-title":"Inflammatory Bowel Diseases"},{"issue":"7","key":"10246_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s10620-018-5048-x","volume":"63","author":"A Bar-Gil Shitrit","year":"2018","unstructured":"Bar-Gil Shitrit A, Cohen Y, Hassin O, Ben Ya'acov A, Farkash R, Koslowsky B, Milgrom Y, Livovsky DM, Samueloff A, Goldin E, Grisaru-Granovsky S. Antenatal management for women with inflammatory bowel disease: experience from our \u2018IBD MOM\u2019 clinic. Dig Dis Sci 2018;63(7):1774\u20131781. https:\/\/doi.org\/10.1007\/s10620-018-5048-x","journal-title":"Digestive Diseases and Sciences"},{"key":"10246_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ibd.21028","volume":"16","author":"MD Kappelman","year":"2010","unstructured":"Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis 2010;16:125\u2013133. https:\/\/doi.org\/10.1002\/ibd.21028.","journal-title":"Inflamm Bowel Dis"},{"key":"10246_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/2050640615580893","volume":"3","author":"SB Kashkooli","year":"2015","unstructured":"Kashkooli SB, Andrews JM, Roberts MB, Selinger CP, Leong RW. Inflammatory bowel disease-specific pregnancy knowledge of gastroenterologists against general practitioners and obstetricians. United Eur Gastroenterol J 2015;3:462\u2013470. https:\/\/doi.org\/10.1177\/2050640615580893.","journal-title":"United Eur Gastroenterol J"},{"key":"10246_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6193275","author":"VWM Huang","year":"2016","unstructured":"Huang VWM, Chang HJ, Kroeker KI, Goodman KJ, Hegadoren KM, Dieleman LA, Fedorak RN. Management of inflammatory bowel disease during pregnancy and breastfeeding varies widely: a need for further education. Can J Gastroenterol Hepatol. 2016. https:\/\/doi.org\/10.1155\/2016\/6193275.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10246_CR18","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/ueg2.70122","volume":"13","author":"MJ Casanova","year":"2025","unstructured":"Casanova MJ, Gisbert J, Amiot A, Gordon H, Fiorino G, Flanagan E, Kotze PG, Sokic-Milutinovic A, Sonnenberg E, Nunez P, Blesl A, Catalan-Serra I, Bossuyt P, Filip R, Bar-Gil Shitrit A, Kagramanova A, Krznaric Z, Molander P, Mantzaris GJ, Juillerat P, Molnar T, Gecse KB, Torres J, Myrelid P, Mahadevan U, Marquez JR, Iade-Vergara BM, Rausch A, Duricova D, Julsgaard M, Chaparro M. International survey of gastroenterologists on managing inflammatory bowel disease during pregnancy and lactation: current state and the necessity for improvements. United Eur Gastroenterol J 2025;13:1999\u20132011. https:\/\/doi.org\/10.1002\/ueg2.70122.","journal-title":"United Eur Gastroenterol J"},{"key":"10246_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/fampra\/cms035","volume":"30","author":"D Toomey","year":"2013","unstructured":"Toomey D, Waldron B. Family planning and inflammatory bowel disease: the patient and the practitioner. Family Pract 2013;30:64\u201368. https:\/\/doi.org\/10.1093\/fampra\/cms035.","journal-title":"Family Pract"},{"key":"10246_CR20","first-page":"803","volume":"10","author":"R Rhodes","year":"2014","unstructured":"Rhodes R, Smith Z, Adams J, Stoner J, Ali T. Assessment of physicians\u2019 perceived risk of inflammatory bowel disease medications in pregnant patients. Gastroenterol Hepatol 2014;10:803\u2013808.","journal-title":"Gastroenterol Hepatol"},{"key":"10246_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/ibd\/izac101","volume":"29","author":"E Liu","year":"2023","unstructured":"Liu E, Laube R, Leong RW, Fraser A, Selinger C, Limdi JK. Managing inflammatory bowel disease in pregnancy: health care professionals\u2019 involvement, knowledge, and decision-making. Inflamm Bowel Dis 2023;29:522\u2013530. https:\/\/doi.org\/10.1093\/ibd\/izac101.","journal-title":"Inflamm Bowel Dis"},{"key":"10246_CR22","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.dld.2023.01.149","volume":"55","author":"S Vieujean","year":"2023","unstructured":"Vieujean S, De Vos M, D\u2019Amico F, Paridaens K, Daftary G, Dudkowiak R, Peyrin-Biroulet L, Danese S. Inflammatory bowel disease meets fertility: a physician and patient survey. Digest Liver Dis 2023;55:888\u2013898. https:\/\/doi.org\/10.1016\/j.dld.2023.01.149.","journal-title":"Digest Liver Dis"},{"key":"10246_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3037128","author":"P Tandon","year":"2021","unstructured":"Tandon P, Diong C, Chong RY, Nguyen GC. Regional variation in pregnancy outcomes amongst women in inflammatory bowel disease: a population-based cohort study. Can J Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1155\/2021\/3037128.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10246_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082644","author":"E De Dycker","year":"2025","unstructured":"De Dycker E, Lenie S, Ceulemans M, Geens P, Lambrechts T, Loddewijkx E, Paps A, Degry J, D\u2019Hondt C, Matthijs A, Vermeire S, Sabino J, Verstockty B, Lannoo L, Van Calsteren K, Ferrante M. The development of a multidisciplinary care pathway for patients with inflammatory bowel disease before, during and after pregnancy. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14082644.","journal-title":"J Clin Med"},{"key":"10246_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2024-001669","author":"G Le Cosquer","year":"2023","unstructured":"Le Cosquer G, Gilletta C, Beoletto F, Bournet B, Buscail L, di Donato E. Contraception, fertility and inflammatory bowel disease (IBD): a survey of the perspectives of patients, gastroenterologists and women\u2019s healthcare providers. BMJ Open Gastroenterol. 2023. https:\/\/doi.org\/10.1136\/bmjgast-2024-001669.","journal-title":"BMJ Open Gastroenterol"},{"key":"10246_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pec.2013.09.013","volume":"94","author":"LM Gawron","year":"2013","unstructured":"Gawron LM, Hammond C, Keefer L. Documentation of reproductive health counselling and contraception in women with inflammatory bowel diseases. Patient Educat Counsell 2013;94:134\u2013137. https:\/\/doi.org\/10.1016\/j.pec.2013.09.013.","journal-title":"Patient Educat Counsell"},{"key":"10246_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1136\/gutjnl-2018-317610","volume":"68","author":"SN Vigod","year":"2019","unstructured":"Vigod SN, Kurdyak P, Brown HK, Nguyen GC, Targownik LE, Seow CH, Kuenzig ME, Benchimol EI. Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort study. Gut 2019;68:1597\u20131605. https:\/\/doi.org\/10.1136\/gutjnl-2018-317610.","journal-title":"Gut"},{"key":"10246_CR28","doi-asserted-by":"publisher","unstructured":"Butani N, Perera S, Srikanth V, Mehra V, O'Connor K, Xiao K, Patel Y, Maxwell C, Griller N, Zenlea T, Premjeyanth V, Vigod S,Huang V. Evaluating the impact of inflammatory bowel disease on mental health during pregnancy: a retrospective survey study. J Crohns Colitis 360 2026;8(3):otag070. https:\/\/doi.org\/10.1093\/crocol\/otag070.","DOI":"10.1093\/crocol\/otag070"},{"key":"10246_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jgh3.12442","volume":"5","author":"EK Flanagan","year":"2020","unstructured":"Flanagan EK, Richmond J, Thompson AJ, Desmond PV, Bell SJ. Addressing pregnancy-related concerns in women with inflammatory bowel disease: insights from the patient\u2019s perspective. J Gastroenterol Hepatol Open 2020;5:28\u201333. https:\/\/doi.org\/10.1002\/jgh3.12442.","journal-title":"J Gastroenterol Hepatol Open"},{"key":"10246_CR30","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9870","author":"MS Keller","year":"2018","unstructured":"Keller MS, Mosadeghi S, Cohen ER, Kwan J, Spiegel BMR. Reproductive health and medication concerns for patients with inflammatory bowel disease: thematic and quantitative analysis using social listening. J Med Internet Res. 2018. https:\/\/doi.org\/10.2196\/jmir.9870.","journal-title":"J Med Internet Res"},{"key":"10246_CR31","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/ecco-jcc\/jjad074","volume":"17","author":"P Tandon","year":"2023","unstructured":"Tandon P, Huang VW, Feig DS, Saskin R, Maxwell C, Gao Y, Fell DB, Seow CH, Snelgrove JW, Nguyen GC. Differences in healthcare utilization in women with and without inflammatory bowel diseases during preconception, pregnancy and postpartum: a population-based cohort study. J Crohn\u2019s Colitis 2023;17:1587\u20131595. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad074.","journal-title":"J Crohn\u2019s Colitis"},{"key":"10246_CR32","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00384-022-04185-9","volume":"37","author":"ZI Tarar","year":"2022","unstructured":"Tarar ZI, Farooq U, Zafar MU, Saleem S, Nawaz A, Kamal F, Ghous G, Inayat F, Ghouri YA. A national study of pregnancy-related maternal and fetal outcomes in women with inflammatory bowel disease. Int J Colorect Dis 2022;37:1535\u20131543. https:\/\/doi.org\/10.1007\/s00384-022-04185-9.","journal-title":"Int J Colorect Dis"},{"key":"10246_CR33","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/jcm11102919","volume":"11","author":"G Lever","year":"2022","unstructured":"Lever G, Chipeta H, Glanville T, Selinger C. Risk of adverse pregnancy outcomes for women with IBD in an expert IBD antenatal clinic. J Clin Med 2022;11:2919\u20132928. https:\/\/doi.org\/10.3390\/jcm11102919.","journal-title":"J Clin Med"},{"key":"10246_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129567","author":"HA Boyd","year":"2015","unstructured":"Boyd HA, Basit S, Harpsoe MC, Wohlfahrt J, Jess T. Inflammatory bowel disease and risk of adverse pregnancy outcomes. PLoS One. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0129567.","journal-title":"PLoS One"},{"key":"10246_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","volume":"160","author":"U Mahadevan","year":"2021","unstructured":"Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology 2021;160:1131\u20131139. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.038.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10246-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10246-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10246-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:55:11Z","timestamp":1791388511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10246-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":35,"alternative-id":["10246"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10246-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the declaration of Helsinki and was approved by the research ethics committees of all participating hospitals (lead approval number: HREC\/24413\/Austin-2025).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}